Pharmaceutical Tempo Scan Pacific (TSPC) managed to register an operating result growth of 5.7%, amounted to almost Rp245 billion, during the first quarter (Q1) of 2017. This was such a positive reversal and a sharp contrast compared to its operating profit result in Q1 of 2016 which had declined by 6.4%. TSPC booked net profit of Rp211.7 billion, up 1.1%. While net sales rose 6.6% to Rp2.34 trillion. The Company has huge cash of Rp1.49 trillion as at March.
